While regular multivitamin use is not linked with early or localized prostate cancer, taking too many multivitamins may be associated with an increased risk for advanced or fatal prostate cancers, according to a study in the May 16 issue of the Journal of the National Cancer Institute.
A Web-based program that provides prostate cancer patients with information about different treatment approaches may make deciding which path to follow a little easier, Medical College of Georgia researchers say.
Researchers at the Ontario Cancer Institute at Princess Margaret Hospital have successfully proven that cancer cells alone can be killed by a new cancer drug that is triggered by a laser light, a process known as photodynamic therapy (PDT).
Elsevier announced today the inaugural issue of a new journal, Molecular Oncology ? a journal for discovery-driven translational cancer research, published by Elsevier on behalf of the Federation of European Biochemical Societies (FEBS).
A combination of three different drugs that block the HER-2 receptor, a critical cellular growth signal for some breast cancers, eradicated aggressive breast tumors in mice and could point the way toward developing better treatments in patients, said researchers from the Breast Center at Baylor College of Medicine in a report that appears in the Journal of the National Cancer Institute.
Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) announced that the U.S. Food and Drug Administration has granted tentative approval for the Company’s Abbreviated New Drug Application (ANDA) to market its generic version of Eli Lilly and Co’s cancer treatment Gemzar? (Gemcitabine) for injection, 200 mg base/vial.
While one in four cancer survivors participates in a support group after diagnosis, use of support groups varies considerably by cancer type, and few survivors receive referrals to such programs from their physicians, according to a new study.
A new test may be able to identify women at risk for breast cancer long before a lump appears on a mammogram, according to the makers of the new test, called Halo? Breast Pap Test System.
Fatigue is one of the most common and distressing symptoms cancer patients experience during chemotherapy and radiation treatment, but it’s difficult for health care professionals to accurately assess its severity.
Researchers at the University of Missouri-Columbia recently created a model of proline dehydrogenase, an important cancer-preventing enzyme in the human body, and analyzed how it works. A paper detailing their results was published today in the Journal of Biological Chemistry.